Cargando…

Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance

BACKGROUND: The Movement Disorder Society diagnostic criteria for progressive supranuclear palsy introduced the diagnostic certainty level “suggestive of progressive supranuclear palsy” for clinical conditions with subtle signs, suggestive of the disease. This category aims at the early identificati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grimm, Max-Joseph, Respondek, Gesine, Stamelou, Maria, Arzberger, Thomas, Ferguson, Leslie, Gelpi, Ellen, Giese, Armin, Grossman, Murray, Irwin, David J., Pantelyat, Alexander, Rajput, Alex, Roeber, Sigrun, van Swieten, John C., Troakes, Claire, Meissner, Wassilios G., Nilsson, Christer, Piot, Ines, Compta, Yaroslau, Rowe, James B., Höglinger, Günter U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953080/ https://www.ncbi.nlm.nih.gov/pubmed/32914550 http://dx.doi.org/10.1002/mds.28263

Ejemplares similares

Distribution patterns of tau pathology in progressive supranuclear palsy
por: Kovacs, Gabor G., et al.
Publicado: (2020)

An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability
por: Kurz, Carolin, et al.
Publicado: (2016)

Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease
por: Marx, Svenja, et al.
Publicado: (2012)

DescribePSP and ProPSP: German Multicenter Networks for Standardized Prospective Collection of Clinical Data, Imaging Data, and Biomaterials of Patients With Progressive Supranuclear Palsy
por: Respondek, Gesine, et al.
Publicado: (2021)

Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration
por: Briel, Nils, et al.
Publicado: (2020)

Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for in vitro Assessment of Progressive Supranuclear Palsy Tau Pathology With [(18)F]PI-2620
por: Willroider, Marie, et al.
Publicado: (2021)

Validation of the Parkinson's Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy
por: Klietz, Martin, et al.
Publicado: (2021)

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017
por: Zella, Maria Angela Samis, et al.
Publicado: (2020)

Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson’s Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy
por: Rogozinski, Sophia, et al.
Publicado: (2022)

Single-nucleus chromatin accessibility profiling highlights distinct astrocyte signatures in progressive supranuclear palsy and corticobasal degeneration
por: Briel, Nils, et al.
Publicado: (2022)

The Lived Experiences of People with Progressive Supranuclear Palsy and Their Caregivers
por: Respondek, Gesine, et al.
Publicado: (2022)

Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy
por: Simoes, Fabio A., et al.
Publicado: (2022)

Disrupted structural connectivity of fronto-deep gray matter pathways in progressive supranuclear palsy
por: Abos, Alexandra, et al.
Publicado: (2019)

Assessment of (18)F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
por: Brendel, Matthias, et al.
Publicado: (2020)

Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype
por: Jabbari, Edwin, et al.
Publicado: (2018)

Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1
por: Weber, Axel, et al.
Publicado: (2018)

Does the Anti‐Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? No
por: Höglinger, Günter U.
Publicado: (2021)

Tau deposition patterns are associated with functional connectivity in primary tauopathies
por: Franzmeier, Nicolai, et al.
Publicado: (2022)

Neuropathological and Biomarker Findings in Parkinson’s Disease and Alzheimer’s Disease: From Protein Aggregates to Synaptic Dysfunction
por: Compta, Yaroslau, et al.
Publicado: (2021)

Inferring the sequence of brain volume changes in progressive supranuclear palsy using MRI
por: Franzmeier, Nicolai, et al.
Publicado: (2022)

Multireceptor fingerprints in progressive supranuclear palsy
por: Chiu, Wang Zheng, et al.
Publicado: (2017)

Falls in Progressive Supranuclear Palsy
por: Brown, Fraser S., et al.
Publicado: (2019)

Progressive supranuclear palsy: diagnosis and management
por: Rowe, James B, et al.
Publicado: (2021)

Managing cognition in progressive supranuclear palsy
por: Rittman, Timothy, et al.
Publicado: (2016)

Identifying the genetic components underlying the pathophysiology of movement disorders
por: Ezquerra, Mario, et al.
Publicado: (2011)

Presentations and mechanisms of CNS disorders related to COVID-19
por: Bodro, Marta, et al.
Publicado: (2020)

Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy
por: Kwasny, Mary J., et al.
Publicado: (2021)

Language impairment in progressive supranuclear palsy and corticobasal syndrome
por: Peterson, Katie A., et al.
Publicado: (2019)

Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
por: Viscidi, Emma, et al.
Publicado: (2021)

Co‐Occurrence of Apathy and Impulsivity in Progressive Supranuclear Palsy
por: Kok, Zi Q., et al.
Publicado: (2021)

Structural and Functional Thalamic Changes in Progressive Supranuclear Palsy
por: Tan, Sean YW, et al.
Publicado: (2022)

Hemichorea as Presentation of Acute Cortical Ischemic Stroke. Case Series and Review of the Literature
por: Carbayo, Álvaro, et al.
Publicado: (2020)

Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy()
por: Hughes, Laura E., et al.
Publicado: (2013)

Structural correlates of survival in Progressive Supranuclear Palsy
por: Street, Duncan, et al.
Publicado: (2023)

Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration
por: Illán-Gala, Ignacio, et al.
Publicado: (2022)

Altered network stability in progressive supranuclear palsy
por: Whiteside, David J, et al.
Publicado: (2021)

Accurate digital quantification of tau pathology in progressive supranuclear palsy
por: Pansuwan, Tanrada, et al.
Publicado: (2023)

Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study
por: Pereira, Marta F, et al.
Publicado: (2022)

Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy
por: Höglinger, Günter U., et al.
Publicado: (2011)

Validation of the new pathology staging system for progressive supranuclear palsy
por: Briggs, Mayen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i889shhuah8ajji7kbnuaqg039